Opendata, web and dolomites

SUPAIR Spectroscopy

SUPAIR Spectroscopy: Single-Use Process Analytical Infrared Spectroscopy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUPAIR Spectroscopy project word cloud

Explore the words cloud of the SUPAIR Spectroscopy project. It provides you a very rough idea of what is the project "SUPAIR Spectroscopy" about.

sterilization    first    efficiency    team    requiring    ftir    bioreactors    probes    usually    accelerator    feasibility    competing    biopharma    biologic    infrared    commercial    single    fourier    optimal    sme    atr    award    energy    cell    awarded    model    silicon    consecutive    billion    compact    500    flexible    patent    b2b    offers    complete    total    techniques    medical    300    companies    costing    eliminates    spectrometer    transform    sub    automated    size    monitoring    merits    online    water    price    industry    customers    irubis    drugs    roadmap    pat    crystal    pending    time    streams    performed    exist    revenue    monitored    impressive    distributors    150    expensive    spectroscopy    mammalian    flow    valley    affordable    carry    half    reactors    direct    read    sales    scholarship    mir    reused    solutions    biopharmaceutical    merck    business    cultivating    sensors    savings    mid    attenuated    poised    2025    innovation    optical    promoted    reflectance    market    technologies    quality    analytical    company    render    cells    solution    consumption    200   

Project "SUPAIR Spectroscopy" data sheet

The following table provides information about the project.

Coordinator
IRUBIS GMBH 

Organization address
address: SCHILLERSTRASSE 40 B
city: MUNCHEN
postcode: 80336
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://irubis.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IRUBIS GMBH DE (MUNCHEN) coordinator 50˙000.00

Map

 Project objective

The biopharmaceutical industry is poised to reach an impressive market size of more than €300 billion by 2025. The production of biologic drugs is usually performed by cultivating mammalian cells within bioreactors. Those reactors are increasingly being monitored online by means of Process Analytical Technologies (PAT). However state-of-the-art techniques render both sub-optimal product quality and product efficiency. A complete mid-infrared (MIR) spectroscopy system using online Attenuated Total Reflectance (ATR) probes is highly expensive costing around €200,000, €20,000 only for the probes that are not robust enough, requiring consecutive sterilization to be reused (raising water and energy consumption). IRUBIS GmbH team goal is to make online monitoring of (single-use) bioreactors affordable. IRUBIS innovation comprises a single-use patent-pending silicon ATR crystal integrated in a single-use ATR Flow Cell which is read out by a compact Fourier Transform Infrared (FTIR) Spectrometer. IRUBIS Analytical Technology offers a system that will allow for the first time real-time process control (online) in single-use bioreactors. This means a flexible, highly automated system solution that costs half the price of the competing solutions. Furthermore, it eliminates sterilization requirements allowing for important energy savings. IRUBIS has been awarded an accelerator program promoted by Merck; Company recent merits also include the Medical valley award (€500,000) and the Exist scholarship (€150,000). Our business model will be based in two revenue streams: B2B direct sales of developed IRUBIS optical sensors to biopharma companies and sales through partnerships with distributors. The feasibility study we will carry out under this SME Phase 1 project, will define the technical, market and commercial roadmap allowing to offer customers a higher value product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPAIR SPECTROSCOPY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPAIR SPECTROSCOPY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

APS (2019)

On-site and On-demand Flexible Packaging System

Read More